Menu

Current Studies

Influenza Vaccine for Cardiovascular Patients


A multicenter, prospective, randomized, double-blind, active-controlled trial comparing two doses of influenza vaccine in high risk cardiovascular patients (history of myocardial infarction or heart failure)

Sign Up

Rheumatoid Arthritis /Positive ANA/Lupus


A collection trial for subjects 18 years or older with a rheumatology condition including but not limited to rheumatoid arthritis (RA) and/or subjects with positive antinuclear antibody (ANA) test results associated with diagnosis of: lupus erythromatosus, scleroderma, Sjogren's Syndrome, polymyositis/dermatomyositis, mixed connective tissue disease, drug-induced lupus, autoimmune hepatitis, and/or juvenile arthritis.

Sign Up

Crohn's Disease- HUMIRA Versus Biosimilar Drug


BI 695501 versus HUMIRA in patients with active Crohn's Disease: a randomized, double-blind, multicenter, parallel group, non-inferiority trial comparing efficacy, endoscopic improvement, sarety, and immunogenicity.

Sign Up

Crohn's Disease- Moderate to Severe


A multicenter, randomized, double-blind, placebo-controlled induction study of the efficacy and safety of Risankizumab in subjects with moderately to severely active Crohn's Disease

Sign Up

Crohn's Disease- Moderate to Severe Who Failed Biologic Treatment


A multicenter, randomized, double-blind, placebo-controlled induction study of the efficacy and safety of Risankizumab in subjects with moderately to severely active Crohn's Disease who failed prior biologic treatment

Sign Up

Irritable Bowel Syndrome


Real-World Perception of Tolerability And Bowel Function Effects of Fuco-N-Tetraose in IBS Patients

Sign Up

Heart-FID- Treatment for Heart Failure with Iron Deficiency


The primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carbocymaltose (FCM), relative to placebo, in the treatment of participants in heart failure with reduced ejection fraction and with iron deficiency.

Sign Up